James H. Wikel
Directeur Technique/Scientifique/R&D chez Apexian Pharmaceuticals, Inc.
Profil
James H.
Wikel is currently the Head of Research & Development at Apexian Pharmaceuticals, Inc. He was previously a Principal at Eli Lilly & Co. from 1971 to 2004 and the Chief Technology Officer at Coalesix, Inc. He received his undergraduate and graduate degrees from Marshall University.
Postes actifs de James H. Wikel
Sociétés | Poste | Début |
---|---|---|
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de James H. Wikel
Sociétés | Poste | Fin |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Coalesix, Inc. | Directeur Technique/Scientifique/R&D | - |
Formation de James H. Wikel
Marshall University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 2 |
---|---|
Coalesix, Inc. | |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Health Technology |